☆ 4.7 Editorial Material

The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors

CARDIOVASCULAR DIABETOLOGY (2018)

Get Full Text
Add to Collection

Journal

CARDIOVASCULAR DIABETOLOGY
Volume 17, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12933-018-0674-3

Keywords

Glucagon-like peptide 1 receptor; Dipeptidyl peptidase-4 inhibitors; Stroke; Diabetes

Categories

Cardiac & Cardiovascular Systems Endocrinology & Metabolism

Funding

  1. Hjart-Lungfonden
  2. Novo Nordisk Foundation
  3. Boehringer Ingelheim Pharma GmbH Co
  4. STROKE-Riksforbundet

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.